Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Reneo Pharmaceuticals Inc
(NQ:
RPHM
)
1.560
+0.090 (+6.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Reneo Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
Nasdaq Turns Lower; US Retail Sales Top Estimates
December 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.04% to 37,105.00 while the NASDAQ fell 0.44% to 14,669.25. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 14, 2023
Via
Benzinga
Recap: Reneo Pharmaceuticals Q3 Earnings
November 13, 2023
Via
Benzinga
Reneo Pharmaceuticals: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Why Is Genetic Disease Focused Reneo Pharmaceuticals Stock Plummeting Today?
December 14, 2023
Reneo Pharmaceuticals Inc (NASDAQ: RPHM) shares are sinking after the company released data from its pivotal STRIDE Phase 2b study of mavodelpar in adult patients with primary mitochondrial myopathies...
Via
Benzinga
Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
December 14, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
November 13, 2023
Topline data results from the pivotal STRIDE study are expected in December 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
November 02, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings
October 25, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
October 09, 2023
Topline data results from the STRIDE study are expected in December 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit
October 06, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results
August 10, 2023
Topline results of the STRIDE study, the pivotal mavodelpar clinical trial in adult patients with primary mitochondrial myopathies (PMM) due to mitochondrial DNA (mtDNA) defects, anticipated in 4Q23
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 3, 2023
July 03, 2023
Via
Benzinga
Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum
June 30, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices
June 26, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
June 15, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
May 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
May 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
May 11, 2023
Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Via
Benzinga
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
May 11, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 04, 2023
Via
Benzinga
Why Arconic Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 04, 2023
Gainers Almaden Minerals Ltd. (NYSE: AAU) gained 72.3% to $0.2111 in pre-market trading after gaining 2% on Wednesday.
Via
Benzinga
PacWest Bancorp, Upwork, Tripadvisor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 04, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Reneo Announces Pricing of Public Offering of Common Stock
May 03, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 03, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 27, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.